Gapping up
In reaction to strong earnings/guidance: MY +5.2%
M&A news: RNA +62.6% (Biomarin Pharm (BMRN) to purchase Prosensa Holding for $17.75 per share), CIMT +42.6% (3D Systems (DDD) to acquire Cimatron for $8.97 per share), PTP +20.2% (to be acquired by RenaissanceRe Holdings (RNR) for $76/share), TTPH +16.6% (may consider sale; possible buyers include Actelion (ALIOF) and Roche (RHHBY), according to reports), RNR+9.9%, BT +3.2% (Telefonica (TEF) may sell O2 to BT Group (BT) in exchange for a 20% BT stake, according to reports), TEF +1%.
Select EU financial related names showing strength: RBS +3.2%, SAN +3.1%, DB +2.9%, BBVA +1.8%, CS +1.5%
Other news: SRPT +8.7% (RNA peer), RGLS +7.2% (RNA peer; also initiated with a Buy at Deutsche Bank), GERN +4.9% (may be related to RNA merger), PBR +3% (cont rebound), TTHI +2.5% (announced results from a thorough QT study in which no QT effects were observed at supra-therapeutic single doses of neuropsychiatric drug candidate, ELND005), TKMR +2.4% (provides key highlights of Analyst and Investor Day), SNSS +2.4% (announces publication of REVEAL-1 Trial results in the British Journal of Haematology), ARIA +2.1% (announced the marketing approval of Iclusig (ponatinib) in Australia), TSLA +1.6% (indicated company may partner with BMW (BAMXY) and build Germany battery plant), JKS +1.6% ( to supply 7MW solar PV modules to Almacen Sustentable in Mexico), SUNE +1.4% (SunEdison and Renova Energia announce JV to develop 1 gigawatt of utility scale solar energy in Brazil), NLNK +1.3% (co & Merck (MRK) enter into licensing and collaboration agreement for investigational ebola vaccine), CSIQ +1.3% (Dominion acquired West Antelope Solar Park from Canadian Solar (CSIQ)), YGE +1% (signed a landmark agreement to supply 120 MW of YGE 72 Cell solar panels for a 300 MW project in France), AMT +0.9% (agrees to acquire TIM tower portfolio in Brazil)
Analyst comments: LL +4.1% (upgraded to Overweight from Equal-Weight at Morgan Stanley), BLOX +4% (upgraded to Buy from Hold at Needham), ARUN +3.5% (upgraded to Outperform from Mkt Perform at Raymond James), KATE +3.4% (upgraded to Buy from Neutral at BofA/Merrill), SCTY +3% (upgraded to Outperform from Neutral at Robert W. Baird), OXY +0.7% (upgraded to Strong Buy from Outperform at Raymond James)
In reaction to strong earnings/guidance: MY +5.2%
M&A news: RNA +62.6% (Biomarin Pharm (BMRN) to purchase Prosensa Holding for $17.75 per share), CIMT +42.6% (3D Systems (DDD) to acquire Cimatron for $8.97 per share), PTP +20.2% (to be acquired by RenaissanceRe Holdings (RNR) for $76/share), TTPH +16.6% (may consider sale; possible buyers include Actelion (ALIOF) and Roche (RHHBY), according to reports), RNR+9.9%, BT +3.2% (Telefonica (TEF) may sell O2 to BT Group (BT) in exchange for a 20% BT stake, according to reports), TEF +1%.
Select EU financial related names showing strength: RBS +3.2%, SAN +3.1%, DB +2.9%, BBVA +1.8%, CS +1.5%
Other news: SRPT +8.7% (RNA peer), RGLS +7.2% (RNA peer; also initiated with a Buy at Deutsche Bank), GERN +4.9% (may be related to RNA merger), PBR +3% (cont rebound), TTHI +2.5% (announced results from a thorough QT study in which no QT effects were observed at supra-therapeutic single doses of neuropsychiatric drug candidate, ELND005), TKMR +2.4% (provides key highlights of Analyst and Investor Day), SNSS +2.4% (announces publication of REVEAL-1 Trial results in the British Journal of Haematology), ARIA +2.1% (announced the marketing approval of Iclusig (ponatinib) in Australia), TSLA +1.6% (indicated company may partner with BMW (BAMXY) and build Germany battery plant), JKS +1.6% ( to supply 7MW solar PV modules to Almacen Sustentable in Mexico), SUNE +1.4% (SunEdison and Renova Energia announce JV to develop 1 gigawatt of utility scale solar energy in Brazil), NLNK +1.3% (co & Merck (MRK) enter into licensing and collaboration agreement for investigational ebola vaccine), CSIQ +1.3% (Dominion acquired West Antelope Solar Park from Canadian Solar (CSIQ)), YGE +1% (signed a landmark agreement to supply 120 MW of YGE 72 Cell solar panels for a 300 MW project in France), AMT +0.9% (agrees to acquire TIM tower portfolio in Brazil)
Analyst comments: LL +4.1% (upgraded to Overweight from Equal-Weight at Morgan Stanley), BLOX +4% (upgraded to Buy from Hold at Needham), ARUN +3.5% (upgraded to Outperform from Mkt Perform at Raymond James), KATE +3.4% (upgraded to Buy from Neutral at BofA/Merrill), SCTY +3% (upgraded to Outperform from Neutral at Robert W. Baird), OXY +0.7% (upgraded to Strong Buy from Outperform at Raymond James)